The U.S. Food and Drug Administration’s approval of Viz.ai’s hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software.
WHY IT MATTERS
Viz.ai, a disease detection and intelligent care coordination company, said in its announcement…
Source: Healthcareitnews.com and Read More
He downloaded a WhatsApp image. Minutes later, Rs 2 lakh was gone | Technology News
Pradeep Jain lost Rs 2.01 lakh from his bank account after hackers gained access to his phone through a scam using Least Significant Bit (LSB)
